Publications by authors named "Metis Hasipek"

Claim this Profile
A
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes.
Nathan Radakovich, David A Sallman, Rena Buckstein, Andrew Brunner, Amy Dezern, Metis Hasipek

iScience· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.
Sunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, Vera Adema, Metis Hasipek

Leukemia· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Myeloma Therapy: Emerging Trends and Challenges.
Danai Dima, Dongxu Jiang, Divya Jyoti Singh, Metis Hasipek, Haikoo S Shah

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.
Yihong Guan, Metis Hasipek, Dongxu Jiang, Anand D Tiwari, Dale R Grabowski

J Clin Invest· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma.
Metis Hasipek, Dale Grabowski, Yihong Guan, Raghunandan Reddy Alugubelli, Anand D Tiwari

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.
Xiaorong Gu, Rita Tohme, Benjamin Tomlinson, Nneha Sakre, Metis Hasipek

Leukemia· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Yihong Guan, Anand D Tiwari, James G Phillips, Metis Hasipek, Dale R Grabowski

Blood Cancer Discov· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET-dioxygenase deficiency in oncogenesis and its targeting for tumor-selective therapeutics.
Yihong Guan, Metis Hasipek, Anand D Tiwari, Jaroslaw P Maciejewski, Babal K Jha

Semin Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.
Anna Kondratova, HyeonJoo Cheon, Beihua Dong, Elise G Holvey-Bates, Metis Hasipek

EMBO J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia.
Yihong Guan, Edward F Greenberg, Metis Hasipek, Shi Chen, Xiaochen Liu

Commun Biol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing PARylation by 2',5'-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death.
Anna A Kondratova, HyeonJoo Cheon, Beihua Dong, Elise G Holvey-Bates, Metis Hasipek

EMBO J· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates.
Xiaorong Gu, Quteba Ebrahem, Reda Z Mahfouz, Metis Hasipek, Francis Enane

J Clin Invest· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a 4.9-kilo base-pair Alu-mediated founder SDHD deletion in two extended paraganglioma families from Austria.
Andreas R Janecke, Joan E Willett-Brozick, Christoph Karas, Metis Hasipek, Judith Loeffler-Ragg

J Hum Genet· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum amyloid A1 -13 T/C alleles in Turkish familial Mediterranean fever patients with and without amyloidosis.
Nejat Akar, Metis Hasipek, Ayşenur Oztürk, Ece Akar, Mustafa Tekin

J Nephrol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis.
Nejat Akar, Metis Hasipek, Ece Akar, Mesiha Ekim, Fatos Yalçinkaya

Amyloid· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour Necrosis Factor-Alpha Gene Polymorphism (-308 G-A) in Turkish Pediatric Thrombosis Patients.
Nejat Akar, Metis Hasipek

Turk J Haematol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis